+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Oncology Drugs Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025

  • ID: 4896719
  • Report
  • November 2019
  • Region: Global
  • 116 pages
  • 360iResearch
UP TO OFF
until May 31st 2020
1 of 3

FEATURED COMPANIES

  • AbbVie Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Celgene Corporation
  • F. HOFFMANN-LA ROCHE LTD.
  • JOHNSON & JOHNSON
  • MORE
The Global Oncology Drugs Market is expected to grow from USD 94,523.46 Million in 2018 to USD 154,235.36 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 7.24%.

The positioning of the Global Oncology Drugs Market vendors in the FPNV Positioning Matrix are determined by Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinders, N: Niche, and V: Vital).

The report explores the recent significant developments by the leading vendors and innovation profiles in the Global Oncology Drugs Market including are AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, F. HOFFMANN-LA ROCHE LTD., Celgene Corporation, JOHNSON & JOHNSON, Merck & Co., Inc., Novartis AG, and Pfizer Inc..

On the basis of Indication, the Global Oncology Drugs Market is examined across Bladder Cancer, Breast Cancer, Cervical Cancer, Colorectal Cancer, Esophagus Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Prostate Cancer, and Stomach Cancer.

On the basis of Drug Class Type, the Global Oncology Drugs Market is examined across Chemotherapy, Hormonal Therapy, Immunotherapy, and Targeted Therapy.

On the basis of Distribution, the Global Oncology Drugs Market is examined across Hospitals Pharmacies, Online Pharmacies, and Retail Pharmacies.

For the detailed coverage of the study, the market has been geographically divided into the Americas, Asia-Pacific, and Europe, Middle East & Africa. The report provides details of qualitative and quantitative insights about the major countries in the region and taps the major regional developments in detail.

In the report, we have covered two proprietary models, the FPNV Positioning Matrix and Competitive Strategic Window. The FPNV Positioning Matrix analyses the competitive market place for the players in terms of product satisfaction and business strategy they adopt to sustain in the market. The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisitions strategies, geography expansion, research & development, new product introduction strategies to execute further business expansion and growth.

Research Methodology:

The market forecasting is based on a market model derived from market connectivity, dynamics, and identified influential factors around which assumptions about the market are made. These assumptions are enlightened by fact-bases, put by primary and secondary research instruments, regressive analysis and an extensive connect with industry people. Market forecasting derived from in-depth understanding attained from future market spending patterns provides quantified insight to support your decision-making process. The interview is recorded, and the information gathered in put on the drawing board with the information collected through secondary research.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Oncology Drugs Market
2. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments in the Global Oncology Drugs Market
3. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets for the Global Oncology Drugs Market
4. Market Diversification: Provides detailed information about new products launches, untapped geographies, recent developments, and investments in the Global Oncology Drugs Market
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the Global Oncology Drugs Market

The report answers questions such as:

1. What is the market size of the Oncology Drugs market?
2. What are the factors that affect the growth in the Global Oncology Drugs Market over the forecast period?
3. What is the competitive position in the Global Oncology Drugs Market?
4. Which are the best product areas to be invested in over the forecast period in the Global Oncology Drugs Market?
5. What are the opportunities in the Global Oncology Drugs Market?
6. What are the modes of entering the Global Oncology Drugs Market?
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • AbbVie Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Celgene Corporation
  • F. HOFFMANN-LA ROCHE LTD.
  • JOHNSON & JOHNSON
  • MORE
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. FPNV Positioning Matrix
2.3.2.1. Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support

3. Executive Summary
3.1. Outlook in the Oncology Drugs Market
3.2. Opportunities in the Oncology Drugs Market

4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Porter's Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends

5. Global Oncology Drugs Market, by Indication
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. Bladder Cancer
5.4. Breast Cancer
5.5. Cervical Cancer
5.6. Colorectal Cancer
5.7. Esophagus Cancer
5.8. Kidney Cancer
5.9. Liver Cancer
5.10. Lung Cancer
5.11. Prostate Cancer
5.12. Stomach Cancer

6. Global Oncology Drugs Market, by Drug Class Type
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Chemotherapy
6.4. Hormonal Therapy
6.5. Immunotherapy
6.6. Targeted Therapy

7. Global Oncology Drugs Market, by Distribution
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Hospitals Pharmacies
7.4. Online Pharmacies
7.5. Retail Pharmacies

8. Global Oncology Drugs Market, by Geography
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. Americas
8.3.1. Overview
8.3.2. Market Sizing & Forecasting
8.3.3. Argentina
8.3.4. Brazil
8.3.5. Canada
8.3.6. Mexico
8.3.7. United States
8.4. Asia-Pacific
8.4.1. Overview
8.4.2. Market Sizing & Forecasting
8.4.3. Australia
8.4.4. China
8.4.5. India
8.4.6. Japan
8.5. Europe, Middle East & Africa
8.5.1. Overview
8.5.2. Market Sizing & Forecasting
8.5.3. France
8.5.4. Germany
8.5.5. Italy
8.5.6. Spain
8.5.7. United Kingdom

9. Competitive Landscape
9.1. FPNV Positioning Matrix for Global Oncology Drugs Market
9.2. Market Vendor Ranking Analysis for Global Oncology Drugs Market
9.3. Competitive News Feed Analysis for Global Oncology Drugs Market

10. Company Usability Profiles
10.1. AbbVie Inc.
10.1.1. Overview
10.1.2. Strategy
10.1.3. SWOT
10.2. Astellas Pharma Inc.
10.2.1. Overview
10.2.2. Strategy
10.2.3. SWOT
10.3. AstraZeneca PLC
10.3.1. Overview
10.3.2. Strategy
10.3.3. SWOT
10.4. Bristol-Myers Squibb Company
10.4.1. Overview
10.4.2. Strategy
10.4.3. SWOT
10.5. F. HOFFMANN-LA ROCHE LTD.
10.5.1. Overview
10.5.2. Strategy
10.5.3. SWOT
10.6. Celgene Corporation
10.7. JOHNSON & JOHNSON
10.8. Merck & Co., Inc.
10.9. Novartis AG
10.10. Pfizer Inc.

11. Appendix
11.1. Discussion Guide
11.2. Top Reports
11.2.1. Global Crane Rental Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.2. Global Computer Vision Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.3. Global Payment Gateway Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.4. Global B2B Travel Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.2.5. Global Varicose Vein Treatment Devices Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
11.3. Author Details
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • F. HOFFMANN-LA ROCHE LTD.
  • Celgene Corporation
  • JOHNSON & JOHNSON
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
Note: Product cover images may vary from those shown
Adroll
adroll